Pathogens of Human Significance: Translational COBRE Center
Official title: Translational Approaches for Pathogens of Human Significance
Funded at Rhode Island Hospital · NIH-11394302 · Data updated 2026-11-12
A COBRE center at Rhode Island Hospital aims to reduce illness and deaths from malaria, tuberculosis, schistosomiasis, and Ebola by supporting researchers and building translational pathways.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | August 16, 2025 |
| Project end | July 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $2,394,474 |
| NIH project number | 5P20GM156688-02 |
| Project ID | NIH-11394302 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include children and adolescents in regions with high malaria, schistosomiasis, TB, or Ebola exposure, and researchers or healthcare workers who could participate in capacity-building activities or translational studies.
✕Less likely to help
Individuals not affected by the targeted diseases or those not involved in the translational research activities may not directly benefit.
What this research studies
This grant funds a Center for Biomedical Research Excellence focused on pathogens that heavily affect people, with a hub at the Center for International Health Research. It supports talented researchers through a mentoring and collaboration network to translate basic findings into practice in areas like malaria, TB, schistosomiasis, and Ebola. The program emphasizes team science, cross-institutional collaboration, and capacity building to move discoveries toward real-world health impacts. If you or your child is living in affected regions, this center could accelerate the development of better diagnostics, treatments, or preventive strategies. The work is designed to strengthen local expertise and infrastructure to address these high-burden diseases over the next several years.
Why it matters
Potential benefit: If successful, the project could lead to earlier diagnoses, improved treatments, and better prevention strategies for key infectious diseases affecting children and families.
How similar studies have gone: Past COBRE programs have shown that structured mentoring and cross-institution collaboration improve research outputs and early translational activity.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Friedman, Jennifer F — Rhode Island Hospital
- Study coordinator: Friedman, Jennifer F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.